1
|
Quinn et al., 2005
|
Europe (United Kingdom)
|
Randomized controlled trial
|
Not disclosed
|
2
|
Nawata et al., 2008
|
Asia (Japan)
|
Observational/prospective
|
Government
|
3
|
Brocq et al., 2009
|
Europe (France)
|
Observational/prospective
|
Not disclosed
|
4
|
Tanaka et al., 2010
|
Asia (Japan)
|
Observational/prospective
|
Government
|
5
|
van den Broek et al., 2011
|
Europe (Netherland)
|
Randomized, multicenter, single blind
|
Not disclosed
|
6
|
van der Maas et al., 2012
|
Europe (Netherland)
|
Observational/prospective
|
Not disclosed
|
7
|
Harigai et al., 2012
|
Asia (Japan)
|
Observational/retrospective
|
Government
|
8
|
Hirata et al., 2013
|
Asia (Japan)
|
Observational/prospective
|
Government
|
9
|
Smolen et al., 2013
|
Europe, Latin America, Asia, Australia
|
Randomized controlled trial
|
Industry
|
10
|
Iwamoto et al., 2014
|
Asia (Japan)
|
Observational/prospective
|
Not disclosed
|
11
|
Kádár et al., 2014
|
Europe (Hungary)
|
Retrospective, multicenter, cohort
|
Government
|
12
|
Tanaka et al., 2015
|
Europe (Hungary)
|
Observational/prospective
|
Government
|
13
|
Moghadam et al., 2016
|
Europe (Netherland)
|
Randomized controlled trial, multicenter, open label
|
Government
|
14
|
NCT00808509 (ADMIRE)
|
Europe (Sweden)
|
Randomized, parallel group, open label
|
Industry
|
15
|
NCT00858780 (DOSERA)
|
Europe (Denmark, Finland, Hungary, Iceland, Norway, Sweden)
|
Randomized controlled trial, double blind
|
Industry
|
16
|
NCT00858780 (DOSERA) b
|
Europe (Denmark, Finland)
|
Randomized controlled trial, double blind
|
Industry
|